Reference / Case study 16 / Health & life sciences
MGEN: speaking to employers without disowning what makes a mutual a mutual
The work defined MGEN's B2B brand platform and clarified the wider architecture so its mutualist model could become verifiable value for employers, brokers and employee-beneficiary audiences.
- Client
- MGEN
- Industry group
- Health & Life Sciences
- Specific industry
- Healthcare & Insurance
- Expertise
- B2B brand platform and brand architecture
- Market
- France
- Engagement
- Group health and protection
- Case
- 16
- LED AT
- Labbrand
Context
MGEN: speaking to employers without disowning what makes a mutual a mutual
MGEN is a French mutual insurer historically linked to the public sector and education. It belongs to Groupe VYV alongside Harmonie Mutuelle, MNT and other mutualist, care, support and housing entities.
The group allocation is legible for individual members by professional community, but less so for corporate buyers. In 2025, MGEN, MNT and Harmonie Mutuelle each took responsibility for large-account tenders and broker relationships, making role allocation a commercial operating rule rather than a representational exercise.
The B2B challenge was to translate member-based legitimacy, democratic governance and the absence of shareholders into benefits an employer can verify: cover-to-price value, service quality, pricing stability, solidity and compliance.
A B2B platform is not a consumer platform in a suit. It starts with the real decision process, not with the brand.
Strategic challenge
The questions that structured the work
Our approach
From analysis to usable decisions
Map the decision chain
Read HR, finance, brokers, employee representatives and beneficiaries as distinct links with different needs.
Translate principles into proof
Convert mutualist values into consequences a buyer can verify across price, service, surplus allocation and relationship quality.
Clarify group allocation
Make explicit the role and intervention perimeter of MGEN and sister brands in group health and protection.
Write for tenders and brokers
Formulate a B2B platform that can work in a response document, on a shortlist and through the full sales cycle.
Test post-signature
Check that the promise remains meaningful when quality is judged on reimbursement and service rather than the pitch.
Research and work conducted
What the engagement covered
- A map of the group-health decision chain.
- Translation of mutualist principles into verifiable professional-buyer benefits.
- A B2B platform usable in tender responses and broker relationships.
- Clarification of the wider brand architecture and allocation between group brands.
- Decision rules for overlap between sister brands.
- An articulation between employer and member narratives and differentiated arguments for each decision-chain link.
Business value
A reading that makes trade-offs easier
Sharper tender responses
Verifiable arguments shorten preparation and reduce quality variation across tender responses.
Less internal competition
Explicit allocation prevents sister entities appearing before the same buyer with adjacent propositions.
Better broker use
Arguments built for the intermediary improve presence on decisive shortlists.
Coherence across two audiences
An employer narrative compatible with the member narrative protects the brand in the daily reality of the client organisation.
Deliverables
Objects teams can use beyond the engagement
- A decision-chain map for group health and protection.
- A proof translation of mutualist principles.
- A B2B brand platform for tenders and broker relationships.
- A wider brand-architecture allocation.
- Decision rules for sister-brand overlap.
- Compatible employer and member narratives with differentiated arguments.
Key learnings
What this case makes clear
- A B2B platform is not a consumer platform with hardened vocabulary.
- There is no single target in B2B but a decision chain, each link expecting a different argument.
- A buyer does not buy values; they buy verifiable consequences.
- Architecture has to be clarified before platform, or commercial reality will contradict the narrative.
- A group contract is judged after signature on service, so the promise has to be written for that moment.
FAQ
Frequently asked questions
Why is a B2B platform different from a B2C platform?
Corporate buyers make a collective decision through a chain of roles, specifications, risk and service expectations. Their questions differ from those of individual members.
How can a mutualist advantage become relevant to an employer?
It has to be translated into verifiable consequences such as pricing stability, use of surplus, relationship quality, service and long-term accountability.
Why clarify architecture before writing the platform?
When sister brands can respond to the same tender, an unresolved allocation will contradict even the best narrative in commercial reality.
Why does the broker matter?
The broker may not buy but strongly influences the shortlist and decision process. A platform that ignores them loses a critical link.
When is a group-health promise judged?
After signature, in reimbursements, service and the daily employee experience, not only in the sales presentation.